3/21/2016 - fda perspective
Published 8 years ago • 75 plays • Length 10:22Download video MP4
Download video MP3
Similar videos
-
36:21
3/21 mrt public discussion meeting: presentations (fda perspective and committee overview)
-
3:45:37
1/6/21 - examining the long-term health and economic effects of antimicrobial resistance in the u.s.
-
55:43
2/3/2016 - mitochondrial replacement techniques: ethical, social, and policy considerations
-
35:48
3/21 mrt public discussion meeting: discussion/q&a
-
0:14
highest paid healthcare workers 💰 (that aren't medical doctors) #shorts
-
6:24
one medical device is raising questions about fda’s approval process
-
23:18
risk basics for medical devices
-
5:42
cpap tips from fda
-
57:40
4/21/2016 - session 2: room 100 q&a
-
0:38
ozempic face: a must know side effect
-
6:44
fda tobacco regulatory science fellowship program
-
22:24
6/21/17 - session iii: daniel
-
3:14
medwatch tips & tools (january 2016)
-
36:32
11/17/2016 - panel 3: qa
-
26:33
9/13/16 session 3: harris
-
1:01:37
day 2 - topic #8: stakeholder perspectives
-
39:03
the fda digital health center of excellence and the advancement of digital health technology
-
14:51
3/31/2016 - vendor and manufacturer perspectives - frye
-
24:17
2/13/2017 - session 3: befort
-
17:31
fda regulation of hearing aids
-
14:08
2/22/2021 - session 4: liu
-
19:56
4/21/2016: session 2 - sanders